Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Tuesday, March 31, 2026.
Reported quarterly EPS; no daily interpolation. Q4 FY2026 (2026-03-31): -12.64.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-30.82
EARNINGS PER SHARE (EPS) AVG 3Y
-68.47
EARNINGS PER SHARE (EPS) AVG 5Y
-54.27
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Virax Biolabs Group Limited
Market Cap
$378849.00
Earnings Per Share (EPS)
N/A
TTM Avg
-30.82
3Y Avg
-68.47
5Y Avg
-54.27
Market Cap
$403887.00
Earnings Per Share (EPS)
N/A
TTM Avg
-48.50
3Y Avg
-108.50
5Y Avg
-157.67
Market Cap
$481786.00
Earnings Per Share (EPS)
-2.74
TTM Avg
-4.14
3Y Avg
-35.99
5Y Avg
-26.33
Market Cap
$250443.00
Earnings Per Share (EPS)
N/A
TTM Avg
-446.18
3Y Avg
-284.47
5Y Avg
-299.57
Market Cap
$518606.00
Earnings Per Share (EPS)
-6.04
TTM Avg
-3.52
3Y Avg
-12.52
5Y Avg
-15.85
Market Cap
$545796.00
Earnings Per Share (EPS)
-54.17
TTM Avg
-34.20
3Y Avg
-18.78
5Y Avg
-13.04
Market Cap
$110112.00
Earnings Per Share (EPS)
-56.54
TTM Avg
-2021.61
3Y Avg
-2656.46
5Y Avg
-1785.38
Market Cap
$95475.00
Earnings Per Share (EPS)
N/A
TTM Avg
-5.39
3Y Avg
-4.78
5Y Avg
-3.78
Market Cap
$667469.00
Earnings Per Share (EPS)
N/A
TTM Avg
-8.66
3Y Avg
-10.78
5Y Avg
-46.09
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Virax Biolabs Group Limited (VRAX) | $378849.00 | N/A | -30.82 | -68.47 | -54.27 |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | N/A | -48.50 | -108.50 | -157.67 |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | -2.74 | -4.14 | -35.99 | -26.33 |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | N/A | -446.18 | -284.47 | -299.57 |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | -6.04 | -3.52 | -12.52 | -15.85 |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | -54.17 | -34.20 | -18.78 | -13.04 |
| Silexion Therapeutics Ltd. (SLXN)vs › | $110112.00 | -56.54 | -2021.61 | -2656.46 | -1785.38 |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | N/A | -5.39 | -4.78 | -3.78 |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | N/A | -8.66 | -10.78 | -46.09 |
| PRF Technologies Ltd. (PRFX)vs › | $70884.00 | -11.16 | -405.74 | -2510.68 | -2758.31 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-6.00
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-03-31 | -12.64 |
| 2025-03-31 | -49.00 |
| 2024-03-31 | -84.00 |
| 2023-03-31 | -128.25 |
| 2022-03-31 | -37.50 |
| 2021-03-31 | -14.25 |
| 2020-03-31 | -17.50 |
